Skip to content
  • Home
  • World News
  • Business
  • Aviation
195 news

195News

All the news that's fit to print

  • Home
  • World News
  • Business
  • Aviation
  • Toggle search form
  • Secretary Blinken’s Meeting with Israeli Defense Minister Gallant World News
  • Elite Cares – Elite Cellular’s Impactful Initiative to Give Back Business
  • Coastal Baby Rentals Establishes New Ocean City Office After Years of Serving Shore Families Business
  • Veterinary CRO And CDMO Market Analysis With opportunity segments Business
  • Deluxe Business Solution Launches Hong Kong Limited Company Formation Services Business
  • Assistant Secretary Medina’s Travel to Miami Beach, Florida World News
  • Market Forecast Report for Military Aircraft Oxygen Systems Including Segment Analysis and Strategic Industry Insights Aviation
  • The Naval Vessels and Surface Combatants Market is projected to grow to $49.96 billion by 2030 World News

ZetrOZ Systems’ sam® Ultrasound Technology Expands Clinical Education on Sustained Acoustic Medicine

Posted on October 10, 2022 By NewsEditor
ZetrOZ Systems’ sam® Ultrasound Technology Expands Clinical Education on Sustained Acoustic MedicineZetrOZ Systems’ sam® Ultrasound Technology Expands Clinical Education on Sustained Acoustic MedicineThe wearable sustained acoustic medicine (sam®) treatment has been effectively utilized by sports medicine doctors, athletes and beyond to help rapidly treat tendon, ligament and other soft-tissue injuries.

ZetrOZ Systems’ sam® Ultrasound Technology Expands Clinical Education on Sustained Acoustic Medicine

TRUMBULL, Conn. - October 10, 2022 - (Newswire.com)

ZetrOZ Systems, creator and manufacturer of the sam® wearable ultrasound device product line, is continuing to expand its clinical education program on the benefits of sustained acoustic medicine for soft tissue healing, the usage of the pain relief treatment and attaining health insurance coverage of the pain relief device. 

Sustained Acoustic Medicine (sam®) is the only home-use bioregenerative medical device cleared by the U.S. Food & Drug Administration for the treatment of select medical indications, most commonly for chronic joint pain of the shoulder, knee and elbow, and the treatment of overuse injuries. More than 50 clinical and scientific studies support its effectiveness in healing injuries, restoring function and returning patients to work and everyday activities.

"Our sam® technology is touching thousands of lives daily, and we want to continue providing education to more healthcare providers as a way to bring this innovative intervention forward to Americans who can benefit from this treatment," said Dr. George Lewis, founder and CEO of ZetrOZ Systems. "This technology offers results without the need for opioids or other drugs while treating and healing patients up to 40% faster than standard methodologies."

Clinical education on sam® is directed by Dr. Rod Walters and Dr. Rajiv Mallipudi. Walters is a nationally recognized leader in athletic training with decades of experience at major universities and as a consultant to clients including the National Football League, the Big 12 Athletic Conference and Cirque du Soleil. He was inducted into the National Athletic Trainers Association Hall of Fame in 2005.

Dr. Mallipudi, MD, M.H.S, is a board-certified internal medicine hospitalist physician and assistant clinical professor at the Yale School of Medicine in New Haven, Conn. He is an active clinical researcher on healthcare quality improvement, with projects examining methods to reduce length of stay for hospital patients and to improve patient outcomes.

Walters and Mallipudi have a shared goal of educating physicians, physical therapists and athletic trainers about the benefits and use of the sam® device, in hopes of reducing the need for surgeries and pain medication and improving patients' likelihood of returning to work, sports and normal daily activities. By providing clinical training resources, including online videos, medical professionals now have information on best practices for the drug-free and non-invasive treatment of patients' injuries.

Adherence to a sam® regimen across the repair phase provides a necessary and safe intervention to ensure patients avoid chronic, recurring injuries. Recommended practices are specified in the education materials and include:

  • The sam® treatment can be applied with one or two ultrasound stimulators.
  • The sam® device should be applied a minimum of four times a week.
  • Treatments should be applied incrementally to assess patients' response to treatment, from an initial one-hour treatment to a maximum of four hours per treatment.
  • For acute conditions, treatment duration can range from 4 to 8 weeks.
  • For chronic conditions, treatment can range from 2 to 12 weeks.

Clinical education instructs physicians that sam® can serve as a stand-alone treatment or be used to supplement other treatment approaches to stimulate soft-tissue repair and that its value is as a treatment option that does not require surgery or pain relief medications. 

The sam® treatment also is a cost-effective treatment option. For example, a 2020 study on knee osteoarthritis, published in the Journal of Orthopaedic Surgery and Research, found sam® provided a greater improvement in functional effectiveness per dollar of care than the standard care options. 

ZetrOZ Systems continues to provide education on sam® technology, most recently participating in the annual PHATS (Professional Hockey Athletic Trainers Society) SPHEM (Society of Professional Hockey Equipment Managers) 2022 Conference in June. Findings showed sam® is a non-invasive, non-narcotic alternative to pain, and that the device's ease of use led athletes to return to normal activity after treatment.

To learn more, visit zetrozsystems.com.

About ZetrOZ Systems
ZetrOZ Systems is leading healing innovation in sports medicine, developing wearable bioelectronic devices for the delivery of sustained acoustic medicine (sam®). Researched and funded by the federal government, ZetrOZ is built on proprietary medical technology of +46 patents and is the exclusive manufacturer and developer of sam®, a product line designed for the treatment of acute and chronic musculoskeletal conditions. To learn more, visit zetrozsystems.com.


Contact Information:
Buse Kayar
[email protected]


Press Release Service by Newswire.com

Original Source: ZetrOZ Systems' sam® Ultrasound Technology Expands Clinical Education on Sustained Acoustic Medicine
Business

Post navigation

Previous Post: Kolaboration Ventures Expands Product Lineup Through Mission Nurseries Acquisition
Next Post: laWow Publishes Lawsuits in Wall Street Legal Battle Between Wallentine, Engaged Capital Over Fraud Allegations

Related Posts

  • Global Biocides Market Size, Share, And Growth Analysis For 2024-2033 Business
  • MetaTrader 4 and 5 Applications Are Back in the Apple AppStore Business
  • Trusted Space Extends Leadership in xGEO Domain Awareness Business
  • Electric Vehicle Fires – A Red Herring Business
  • A Retrospective Paintings Exhibition of the Song Dynasty on the occasion of the UN Chinese Language Day Business
  • Global Distribution Transformers Market to Reach USD 56.4 Billion by 2035, Driven by Grid Modernization and Renewables Business
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
« Oct    
last celebrity gossip
Gossip Stone - celebrity life and gossip

Recent Posts

  • Atopic Dermatitis Market Expected to Grow Steadily at a 14.6% CAGR Until 2030November 15, 2026
  • Forecast Report on the Semiconductor Chip Design Market Including Segment Analysis and Strategic Industry InsightsNovember 14, 2026
  • The Assisted Living Technologies Market is projected to grow to $17.76 billion by 2030, expanding at a CAGR of 13.8%November 14, 2026
  • Artificio Launches AI Agents That Work the SAP MRP Exception List Before Planners Start Their DayNovember 13, 2026
  • Asperger Syndrome Market Report Details Key Segments, Regional Developments, and Leading CompetitorsNovember 13, 2026
Brand Values Content
VUGA Enterprises - media network PR & Marketing
  • Southwestern Scale Expands Into Colorado Business
  • Arival Bank Launches Stablecoin Payments through its network of Bank Partners World News
  • Casting Call Announced for New TV Show Showcasing the Cannes Film Festival World News
  • War Day 218: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin
    War Day 218: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin World News
  • War in Ukraine, Analytics. Day 1327: Why Zelensky Is Meeting With Trump. Arestovych, Shelest. World News
  • The Assisted Living Technologies Market is projected to grow to .76 billion by 2030, expanding at a CAGR of 13.8%
    The Assisted Living Technologies Market is projected to grow to $17.76 billion by 2030, expanding at a CAGR of 13.8% Business
  • The Global Narrow-body Aircraft Engine Market is projected to grow at a 9% CAGR throughout the forecast period. Aviation
  • War Day 192: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin World News
aerospace company
stem cell clinic in kiev
medical spa in miami
Fashion TV free

Copyright © 2026 195 News. All Rights Reserved by Coolaser

Powered by .